Menarche, menopause, and migration: Implications for breast cancer research
β Scribed by Lynnette Leidy
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 71 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1042-0533
No coin nor oath required. For personal study only.
β¦ Synopsis
A multigenerational delay in the rise of breast cancer incidence rates has been documented among immigrants to the United States. Prompted by this observation, this study examines three breast cancer risk factors, age at menarche, parity, and age at menopause, in relation to each other and in relation to migration status and language most often used in U.S. Hispanic populations. Mexican American (n = 1,502), Cuban American (n = 534), and Puerto Rican (n = 700) women, aged 30-74 years, were drawn from the Hispanic Health and Nutrition Examination Survey (HHANES), 1982-1984. Mean recalled age at menarche was significantly later among first generation compared to second generation immigrants in both Mexican Americans (13.3 vs 12.8 years) and Puerto Ricans (12.8 vs 11.9 years). Among Mexican Americans, more children were reported by first generation immigrants than women of the third or more generations (4.9 vs 4.0 children) and by Spanish speakers compared to women who used English more frequently (4.5 vs 3.3 children). Mean and median ages at menopause were later among second generation Mexican American women than first generation women. There was a small, significant, positive correlation between recalled ages at menarche and menopause within each of the first generation Hispanic subgroups. The unique positive correlation between ages at menarche and menopause among first generation immigrants may relate to having spent early years in the country of origin and later years in the United States. Am. J. Hum. Biol. 10:451-457, 1998. Β© 1998 Wiley-Liss, Inc.
π SIMILAR VOLUMES
The 1988 International Union Against Cancer-American Joint Committee pathologic staging system for breast cancer provides a distinction between intracapsular axillary lymph node metastases (ICM) and extracapsular axillary metastases (ECM).' This distinction From the
S-phase fraction (SPF), estimated in the flow cytometric DNA histogram, is a prognostic factor in breast cancer. There are, however, some inherent difficulties in the estimation of SPF, such as the influence of debris, aggregates, and normal cells. Most of the available SPF calculation principles tr
Single micrometastatic tumor cells encased in mesenchymal tissues, such as bone marrow (BM), are regarded as suitable targets for adjuvant immunotherapy since they are easily accessible for both immunoglobulins and immune effector cells. However, the antigen profile of such cells, to which antibody